Home LiteratureArticle Details
PMID: 9238051 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal.

Benjamin LE, Keshet E

Abstract

We have recently shown that VEGF functions as a survival factor for newly formed vessels during developmental neovascularization, but is not required for maintenance of mature vessels. Reasoning that expanding tumors contain a significant fraction of newly formed and remodeling vessels, we examined whether abrupt withdrawal of VEGF will result in regression of preformed tumor vessels. Using a tetracycline-regulated VEGF expression system in xenografted C6 glioma cells, we showed that shutting off VEGF production leads to detachment of endothelial cells from the walls of preformed vessels and their subsequent death by apoptosis. Vascular collapse then leads to hemorrhages and extensive tumor necrosis. These results suggest that enforced withdrawal of vascular survival factors can be applied to target preformed tumor vasculature in established tumors. The system was also used to examine phenotypes resulting from over-expression of VEGF. When expression of the transfected VEGF cDNA was continuously "on," tumors became hyper-vascularized with abnormally large vessels, presumably arising from excessive fusions. Tumors were significantly less necrotic, suggesting that necrosis in these tumors is the result of insufficient angiogenesis.

MeSH Terms
Animals Cell Line Endothelial Growth Factors/physiology Gene Expression Regulation, Neoplastic/drug effects Glioma/blood supply Hemangioblastoma/pathology Lymphokines/physiology Mice Mice, Nude Neoplasms, Experimental/blood supply Neovascularization, Pathologic Protein Synthesis Inhibitors/pharmacology Tetracycline/pharmacology Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors
Chemicals
Endothelial Growth Factors Lymphokines Protein Synthesis Inhibitors Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Tetracycline
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Benjamin L E
Department of Molecular Biology, Hadassah Medical School, The Hebrew University, Jerusalem 91120, Israel.
Keshet E
References (38)
38 references, click to expand
  1. Programmed cell death and the control of cell survival.
    Philos Trans R Soc Lond B Biol Sci. 1994 Aug 30;345(1313):265-8 PMID: 7846124
  2. Proliferative potential of vascular components in human glioblastoma multiforme.
    Acta Neuropathol. 1987;73(3):301-5 PMID: 3039783
  3. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.
    Cell. 1996 Aug 9;86(3):353-64 PMID: 8756718
  4. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.
    Nat Med. 1995 Feb;1(2):149-53 PMID: 7585012
  5. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.
    Cancer Res. 1995 Sep 15;55(18):3964-8 PMID: 7664263
  6. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb.
    Lancet. 1996 Aug 10;348(9024):370-4 PMID: 8709735
  7. Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion.
    Lab Invest. 1996 Apr;74(4):771-80 PMID: 8606487
  8. Expression of vascular endothelial growth factor in capillary hemangioblastoma.
    Biochem Biophys Res Commun. 1993 Jul 30;194(2):749-55 PMID: 7688226
  9. Programmed cell death and the control of cell survival: lessons from the nervous system.
    Science. 1993 Oct 29;262(5134):695-700 PMID: 8235590
  10. Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth.
    Cold Spring Harb Symp Quant Biol. 1994;59:471-82 PMID: 7587101
  11. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
    Cancer Res. 1996 Apr 1;56(7):1615-20 PMID: 8603410
  12. Designing therapies that target tumor blood vessels.
    Science. 1997 Jan 24;275(5299):482-4 PMID: 9019809
  13. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells.
    J Biol Chem. 1995 Oct 27;270(43):25915-9 PMID: 7592779
  14. Integrins, adhesion and apoptosis.
    Trends Cell Biol. 1997 Apr;7(4):146-50 PMID: 17708932
  15. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
    Cancer Res. 1995 Mar 15;55(6):1358-64 PMID: 7533661
  16. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.
    Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):768-72 PMID: 7531342
  17. Regulation of basic fibroblast growth factor mRNA expression in rat C6 glioma cells.
    Exp Cell Res. 1993 Dec;209(2):224-30 PMID: 8262139
  18. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
    Nature. 1992 Oct 29;359(6398):843-5 PMID: 1279431
  19. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis.
    Cancer Res. 1993 Dec 1;53(23):5822-7 PMID: 7694795
  20. The use of fluorescent probes to identify regions of transient perfusion in murine tumors.
    Int J Radiat Oncol Biol Phys. 1989 Apr;16(4):931-4 PMID: 2703399
  21. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo.
    Nature. 1993 Apr 29;362(6423):841-4 PMID: 7683111
  22. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
    Nature. 1994 Feb 10;367(6463):576-9 PMID: 8107827
  23. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer.
    Cancer Res. 1993 Sep 15;53(18):4161-3 PMID: 7689928
  24. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
    Nature. 1992 Oct 29;359(6398):845-8 PMID: 1279432
  25. Treating cancer by inhibiting angiogenesis: new hopes and potential pitfalls.
    Cancer Metastasis Rev. 1996 Jun;15(2):231-6 PMID: 8842495
  26. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.
    Nat Med. 1995 Oct;1(10):1024-8 PMID: 7489357
  27. The extracellular matrix as a cell survival factor.
    Mol Biol Cell. 1993 Sep;4(9):953-61 PMID: 8257797
  28. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.
    Oncogene. 1994 Mar;9(3):963-9 PMID: 8108142
  29. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis.
    Cancer Res. 1995 Oct 15;55(20):4575-80 PMID: 7553632
  30. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells.
    J Cell Biol. 1994 Oct;127(2):537-46 PMID: 7523422
  31. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody.
    Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14765-70 PMID: 8962129
  32. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy.
    Cancer Res. 1996 Sep 1;56(17):4032-9 PMID: 8752175
  33. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression.
    Cancer Res. 1995 Dec 15;55(24):6161-5 PMID: 8521408
  34. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
    J Natl Cancer Inst. 1995 Feb 1;87(3):213-9 PMID: 7535859
  35. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization.
    Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7657-61 PMID: 7543999
  36. Intermittent blood flow in a murine tumor: radiobiological effects.
    Cancer Res. 1987 Jan 15;47(2):597-601 PMID: 3791244
  37. Expression of growth factors and growth factor receptors in capillary hemangioblastoma.
    J Neuropathol Exp Neurol. 1996 May;55(5):522-7 PMID: 8627342
  38. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes.
    Mol Cell Biol. 1995 Oct;15(10):5363-8 PMID: 7565686
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1997-08-05
Pages
8761-6
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC23118
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com